Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 4/20 | 0.58 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.38 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7286061 | 1.00 | USP2 (0.58) | USP2TSHRTRPA1MAPTCYP1A2 | |
| SCHEMBL6258389 | 1.00 | USP2 (0.58) | USP2TSHRTRPA1MAPTCYP1A2 | |
| SCHEMBL5857720 | 1.00 | — | — | |
| SCHEMBL11471274 | 1.00 | USP2 (0.58) | USP2TSHRTRPA1MAPTCYP1A2 | |
| SCHEMBL3920827 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL10700530 | 0.92 | USP2 (0.51) | USP2TSHRTRPA1MAPTCYP1A2 | |
| Hydrochloric Acid SCHEMBL10700534 | 0.92 | USP2 (0.51) | USP2TSHRTRPA1MAPTCYP1A2 | |
| SCHEMBL3934528 | 0.89 | — | — | |
| SCHEMBL17965765 | 0.83 | USP2 (0.45) | USP2TSHRTRPA1MAPTABCC4 | |
| SCHEMBL17965766 | 0.83 | USP2 (0.45) | USP2TSHRTRPA1MAPTABCC4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0668904-B1 | FABRIC SCENTING METHOD | FIRMENICH & CIE (CH) | 2001-11-07 | — | — | EP | claimed |
| EP-0668904-A1 | FABRIC SCENTING METHOD | FIRMENICH SA (CH) | 1995-08-30 | — | — | EP | claimed |
| WO-1995004809-A1 | FABRIC SCENTING METHOD | FIRMENICH S.A. (CH) | 1995-02-16 | — | — | WO | claimed |
| CN-105859529-B | Method for producing asymmetric conjugated diyne compound and method for producing Z, Z-conjugated diene compound using the same | 信越化学工业株式会社 | 2020-10-16 | — | — | CN | disclosed |
| EP-2781599-B1 | NUCLEIC ACID FRAGMENT BINDING TO TARGET PROTEIN | TAGCYX BIOTECHNOLOGIES (JP) | 2019-05-08 | — | — | EP | disclosed |
| US-10000775-B2 | Biosynthesis of 1-undecene and related terminal olefins | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2018-06-19 | — | — | US | disclosed |
| US-9873879-B2 | Nucleic acid fragment binding to target protein | TAGCYX BIOTECHNOLOGIES (JP) | 2018-01-23 | — | — | US | disclosed |
| EP-3053906-B1 | METHOD FOR PRODUCING ASYMMETRIC CONJUGATED DIYNE COMPOUND AND METHOD FOR PRODUCING Z,Z-CONJUGATED DIENE COMPOUND USING THE SAME | SHINETSU CHEMICAL CO (JP) | 2017-12-27 | — | — | EP | disclosed |
| US-9845304-B2 | Method for producing asymmetric conjugated diyne compound and method for producing Z,Z-conjugated diene compound using the same | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2017-12-19 | — | — | US | disclosed |
| US-20170073683-A1 | NUCLEIC ACID FRAGMENT BINDING TO TARGET PROTEIN | TAGCYX BIOTECHNOLOGIES (JP) | 2017-03-16 | — | — | US | disclosed |
| US-9540650-B2 | Nucleic acid fragment binding to target protein | TAGCYX BIOTECHNOLOGIES (JP) | 2017-01-10 | — | — | US | disclosed |
| US-6998412-B2 | Heterocyclic compounds | NIPPON SHINYAKU CO., LTD. (JP) | 2006-02-14 | — | — | US | disclosed |
| US-20050009785-A1 | Heterocyclic compounds | KUWABARA KENJI (JP) | 2005-01-13 | — | — | US | disclosed |
| US-20050009892-A1 | Heterocyclic compounds | NIPPON SHINYAKU CO., LTD. (JP) | 2005-01-13 | — | — | US | disclosed |
| US-20040162325-A1 | Heterocyclic compounds | KUWABARA KENJI (JP) | 2004-08-19 | — | — | US | disclosed |
| US-20030166697-A1 | Heterocyclic compounds | NIPPON SHINYAKU CO., LTD. (JP) | 2003-09-04 | — | — | US | disclosed |
| EP-1295875-A1 | HETEROCYCLIC COMPOUNDS | Nippon Shinyaku Co., Ltd. (JP) | 2003-03-26 | — | — | EP | disclosed |
| US-5039674-A | Calcium antagonistics | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1991-08-13 | — | — | US | disclosed |
| US-4782160-A | CALCIUM RECEPTOR ANTAGONISTS | YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) | 1988-11-01 | — | — | US | disclosed |
| EP-0276552-A1 | 1,4-dihydropyridine derivatives and their production | YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) | 1988-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009785-A1 | Heterocyclic compounds | LIPC, GPR119, APOB | USP2 4665/4885TSHR 1666/4885TRPA1 1337/4885 |
| US-20050009892-A1 | Heterocyclic compounds | GPR119, LIPC, LIPE | USP2 4751/4885TSHR 2487/4885TRPA1 1277/4885 |
| US-20040162325-A1 | Heterocyclic compounds | LIPE, GPR119, LIPC | USP2 4660/4885TSHR 2672/4885TRPA1 1795/4885 |
| US-20030166697-A1 | Heterocyclic compounds | LIPE, GPR119, LIPC | USP2 4660/4885TSHR 2672/4885TRPA1 1795/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.